首页> 外文期刊>European journal of ophthalmology >Pneumatic displacement of acute submacular hemorrhage with and without the use of tissue plasminogen activator
【24h】

Pneumatic displacement of acute submacular hemorrhage with and without the use of tissue plasminogen activator

机译:伴或不伴组织纤溶酶原激活剂的急性黄斑下出血的气动置换

获取原文
获取原文并翻译 | 示例
       

摘要

Purpose. To evaluate the efficacy of C3F8 gas-assisted pneumatic displacement in the treatment of massive submacular hemorrhage, with and without the use of tissue plasminogen activator (tPA). Methods. Twenty-one eyes of 21 patients with recently developed (up to 10 days) dense submacular hemorrhage underwent intravitreal injection of pure C3Fa gas (0.4-0.5 mL) followed by face-down positioning for pneumatic displacement. Seven of them received additional intravitreal injection of 25-50 ijg tPA. The primary etiology of submacular hemorrhage was age-related macular degeneration (n=16), myopic choroidal neovascularization (n=2), retinal arterial macroaneurysm (n=2), and trauma (n=1). Visual acuity and displacement of hemorrhage were the main outcome measures. Results. Follow-up period was 6-12 months. Effective displacement of hemorrhage was obtained in 20 of 21 patients within 7 days. Final median Snellen visual acuity (0.18) was found significantly improved compared to baseline (0.03) (p<0.001). Visual acuity improvement was similar in both groups (9=0.72).Conclusions. Intravitreal injection of C3F8 effectively displaced thick submacular hemorrhage and improved visual acuity independently from primary cause. Additional tPA use in this study had no impact on the final outcomes.
机译:目的。评估使用或不使用组织纤溶酶原激活剂(tPA)的C3F8气体辅助气压置换在治疗大规模黄斑下出血的疗效。方法。玻璃体腔注射纯C3Fa气体(0.4-0.5 mL),对21例最近发生(长达10天)密集的黄斑下出血的患者的21只眼睛进行注视,然后朝下放置以进行气压置换。其中七个接受了25-50 ijg tPA的玻璃体内注射。黄斑下出血的主要病因是与年龄相关的黄斑变性(n = 16),近视脉络膜新生血管(n = 2),视网膜动脉大动脉瘤(n = 2)和外伤(n = 1)。视力和出血移位是主要的预后指标。结果。随访时间为6-12个月。在7天内,有21位患者中的20位获得了有效的出血替代。发现最终的Snellen视力中位数(0.18)与基线(0.03)相比有显着改善(p <0.001)。两组的视力改善相似(9 = 0.72)。玻璃体腔内注射C3F8可有效地取代黄斑下出血,并独立于主要病因而改善视力。在这项研究中额外使用tPA对最终结果没有影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号